These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23137138)

  • 1. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.
    Lortholary O; Petrikkos G; Akova M; Arendrup MC; Arikan-Akdagli S; Bassetti M; Bille J; Calandra T; Castagnola E; Cornely OA; Cuenca-Estrella M; Donnelly JP; Garbino J; Groll AH; Herbrecht R; Hope WW; Jensen HE; Kullberg BJ; Lass-Flörl C; Meersseman W; Richardson MD; Roilides E; Verweij PE; Viscoli C; Ullmann AJ;
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 7():68-77. PubMed ID: 23137138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
    Cuenca-Estrella M; Verweij PE; Arendrup MC; Arikan-Akdagli S; Bille J; Donnelly JP; Jensen HE; Lass-Flörl C; Richardson MD; Akova M; Bassetti M; Calandra T; Castagnola E; Cornely OA; Garbino J; Groll AH; Herbrecht R; Hope WW; Kullberg BJ; Lortholary O; Meersseman W; Petrikkos G; Roilides E; Viscoli C; Ullmann AJ;
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 7():9-18. PubMed ID: 23137134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
    Yang YL; Lo HJ; Hung CC; Li Y
    BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.
    Enwuru CA; Ogunledun A; Idika N; Enwuru NV; Ogbonna F; Aniedobe M; Adeiga A
    Afr Health Sci; 2008 Sep; 8(3):142-8. PubMed ID: 19357740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posaconazole for the management of mucosal candidiasis.
    Vazquez JA
    Future Microbiol; 2007 Jun; 2(3):245-56. PubMed ID: 17661697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of causative organisms under antifungal treatment in immunosuppressed patients with HIV-infections.
    Just G; Steinheimer D; Schnellbach M; Böttinger C; Helm EB; Stille W
    Mycoses; 1989; 32 Suppl 2():47-51. PubMed ID: 2700222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of traditional Chinese medicinal herbs on Candida spp. from patients with HIV/AIDS.
    Liu X; Han Y; Peng K; Liu Y; Li J; Liu H
    Adv Dent Res; 2011 Apr; 23(1):56-60. PubMed ID: 21441482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistant candidiasis.
    Powderly WG
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):925-9. PubMed ID: 7811544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
    Vazquez JA
    HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
    Cornely OA; Bassetti M; Calandra T; Garbino J; Kullberg BJ; Lortholary O; Meersseman W; Akova M; Arendrup MC; Arikan-Akdagli S; Bille J; Castagnola E; Cuenca-Estrella M; Donnelly JP; Groll AH; Herbrecht R; Hope WW; Jensen HE; Lass-Flörl C; Petrikkos G; Richardson MD; Roilides E; Verweij PE; Viscoli C; Ullmann AJ;
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 7():19-37. PubMed ID: 23137135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.
    Li YY; Chen WY; Li X; Li HB; Li HQ; Wang L; He L; Yang XP; Wang XC; Huang YL; Yao YG
    BMC Infect Dis; 2013 Jan; 13():46. PubMed ID: 23356471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections by Candida and cryptococci].
    Berenguer J; Blázquez R; Ocaña I; Lozano F
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():29-35. PubMed ID: 9859617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.